Cavitaion vs W-BEMS on Central Obesity

NCT07307898 | Active Not Recruiting

• 1 other identifier: 012/005581
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to compare the effects of ultrasound cavitation and whole-body electromyostimulation (WB-EMS) on inflammatory markers in individuals with central obesity.

Conditions

Central Obesity

Outcome Measures

Primary Outcomes (1)

• Inflammatory Markers

  Measurement of changes in levels of Tumor Necrosis Factor-alpha (TNF-alpha), and Interleukin-6 (IL-6) using ELISA (Enzyme-Linked Immunosorbent Assay) kits.

  3 Monthes

Secondary Outcomes (3)

• Waist Circumference

  3 Monthes

• Body Weight

  3 Monthes

• Body Mass Index (BMI)

  3 Monthes

Study Arms (3)

group A (Study group)

EXPERIMENTAL

Participants in this cohort were administered localized ultrasound cavitation treatments. Each session was approximately 30 minutes in duration, with treatments scheduled twice a week. In addition, participants received mediterranean diet

Device: cavitation, whole body electromyostimulation

group B (Study group)

EXPERIMENTAL

: Participants assigned to this cohort underwent whole- body electromyostimulation (WB-EMS) therapy. These sessions were 20 minutes long, also occurring twice weekly. Participants also received mediterranean diet.

Device: cavitation, whole body electromyostimulation

Group C (Control Group)

SHAM COMPARATOR

Participants in this control group receive mediterranean diet. Additionally, they participated in all assessment procedures, ensuring a comprehensive comparative analysis.

Device: cavitation, whole body electromyostimulation

Interventions

cavitation, whole body electromyostimulation DEVICE

The duration of the study was set for 12 weeks. Assessments were meticulously conducted at both the baseline and the conclusion of the study period to evaluate outcomes across the different groups.

Group C (Control Group); group A (Study group); group B (Study group)

Eligibility Criteria

• Age: 18 Years - 50 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Adults aged 18-50 years.
• Individuals diagnosed with central obesity, defined as a waist circumference greater than 102 cm in men and 88 cm in women.
• Participants with a stable body weight for at least three months prior to the study.
• No engagement in regular physical activity or weight loss programs in the past six months.
• Willingness to adhere to study protocols and attend all scheduled sessions.

You may not qualify if:

• Individuals with chronic diseases other than obesity-related conditions, such as cardiovascular disease, diabetes, or severe hypertension.
• Pregnant or lactating women.
• Individuals with implanted electronic devices (e.g., pacemakers).
• Participants with dermatological conditions or skin infections in the treatment area.
• Individuals undergoing medication that may affect fat metabolism or inflammatory markers.

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Cairo University

Cairo, Qalyubia Governorate, 13611, Egypt

Location

MeSH Terms

Conditions

Obesity, Abdominal

Condition Hierarchy (Ancestors)

Obesity; Overweight; Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: physical therapist

Study Record Dates

• First Submitted: August 26, 2025
• First Posted: December 29, 2025
• Study Start: September 5, 2024
• Primary Completion: November 5, 2024
• Study Completion: January 4, 2026
• Last Updated: December 29, 2025

Record last verified: 2025-12

Locations

EG (1)